Fortress Biotech stock rises after subsidiary’s gout treatment enters Phase 3 trials By Investing.com

Promising New Gout Treatment Advances to Phase 3 Trials: What This Means for Patients

Gout, a painful and debilitating form of inflammatory arthritis, affects millions worldwide. Characterized by sudden and severe attacks of pain, swelling, redness, and tenderness in the joints, often the big toe, gout is caused by a buildup of uric acid in the blood, leading to the formation of urate crystals in the joints. While existing treatments can help manage the condition, research continues to explore new and more effective options.

Recently, Fortress Biotech Inc. (NASDAQ:FBIO) announced that its subsidiary's investigational gout treatment, dotinurad, has entered Phase 3 clinical trials. This development signifies a significant step forward in the search for improved gout management strategies.

Understanding Gout and Hyperuricemia

Before diving into the specifics of the clinical trials, it's crucial to understand the underlying cause of gout: hyperuricemia. Hyperuricemia occurs when there's too much uric acid in the blood. Uric acid is a natural waste product formed from the breakdown of purines, substances found in many foods and also produced by the body.

For many individuals, high uric acid levels don't cause any problems. However, in some, the excess uric acid can crystallize and deposit in the joints, triggering the intense inflammation and pain associated with gout attacks.

Symptoms of Gout

Gout symptoms often appear suddenly and can include:

  • Intense joint pain: Often affecting the big toe, but can occur in other joints like ankles, knees, elbows, wrists, and fingers.
  • Lingering discomfort: After the initial pain subsides, some discomfort may remain for days or even weeks.
  • Inflammation and redness: The affected joint becomes swollen, tender, warm, and red.
  • Limited range of motion: Difficulty moving the affected joint.

Dotinurad: A Potential New Treatment Option

Dotinurad is a selective URAT1 (Urate Transporter 1) inhibitor. This means it works by helping the kidneys remove uric acid from the body, thereby lowering uric acid levels in the blood. By reducing uric acid levels, dotinurad aims to prevent the formation of urate crystals and reduce the frequency and severity of gout attacks.

RUBY and TOPAZ Trials: Evaluating Dotinurad's Effectiveness

The Phase 3 clinical trials, named RUBY and TOPAZ, will evaluate the safety and efficacy of dotinurad in adults with hyperuricemia associated with gout.

  • RUBY Trial: This trial will compare dotinurad to allopurinol, a commonly prescribed medication for gout, in patients with gout. The goal is to assess whether dotinurad is as effective, or potentially more effective, than allopurinol in lowering uric acid levels and managing gout symptoms.
  • TOPAZ Trial: This trial will focus on patients with tophaceous gout. Tophi are deposits of urate crystals that form under the skin around joints, in cartilage, or in other places. The TOPAZ trial will assess dotinurad's ability to reduce tophi and improve the overall condition of patients with this more advanced form of gout.

Managing Gout: Lifestyle and Dietary Recommendations

While new treatments like dotinurad offer hope for improved gout management, lifestyle modifications and dietary changes remain essential components of a comprehensive treatment plan.

Here are some practical tips for managing gout:

  • Hydration: Drink plenty of water to help flush uric acid from the body. Aim for at least 8 glasses of water per day.
  • Limit alcohol consumption: Alcohol, especially beer, can increase uric acid levels.
  • Reduce purine-rich foods: Foods high in purines, such as red meat, organ meats (liver, kidney), and some seafood (anchovies, sardines), can contribute to elevated uric acid levels.
  • Maintain a healthy weight: Obesity is associated with increased uric acid production and a higher risk of gout.
  • Eat cherries or drink cherry juice: Some studies suggest that cherries may help lower uric acid levels and reduce inflammation.
  • Consider coffee: Some research indicates that moderate coffee consumption may be associated with a lower risk of gout.
  • Limit sugary drinks: Fructose-sweetened beverages may increase uric acid levels.
  • Work with your doctor: Regular monitoring of uric acid levels and adherence to prescribed medications are crucial for effective gout management.

[Image of the foot of a person experiencing a gout attack]

Take Control of Your Gout with AI Technology

Managing gout doesn't have to be complicated. GoutSnap AI is a revolutionary mobile app that uses artificial intelligence to analyze your food in real-time and help you make better dietary choices.

Simply snap a photo of your meal, and our AI instantly identifies high-purine foods that could trigger gout attacks. Get personalized recommendations, track your diet history, and prevent flare-ups before they happen.

Key Features:

  • 📸 Instant Food Analysis - Take a photo and get immediate purine content information
  • 🍽️ Dietary Tracking - Monitor your daily purine intake effortlessly
  • 💡 Smart Recommendations - Receive AI-powered suggestions for gout-friendly alternatives
  • 📊 Health Insights - Track patterns and identify your personal triggers

There are a few mobile apps for health, diet and manage gout. However, a several thousand of users has concluded that GoutSnap AI is successfully managing their gout with the power of AI.

Get it on Google Play
Download on the App Store